Initial Determination Decision Protects Validity of Shoals Intellectual PropertyPORTLAND, Tenn., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals”) (Nasdaq: SHLS), a global leader in electrical infrastructure solutions for the energy transition market, announced today that the U.S. International Trade Commission (“ITC”) has issued a favorable initial determination in Shoals’ patent infringement complaint against Voltage, LLC (“Voltage”) and its related foreign entity. On February 6 ...

Core Viewpoint - Canadian Solar Inc. achieved a significant legal victory against Maxeon Solar Pte. Ltd. regarding patent infringement claims, with the PTAB ruling all claims by Maxeon as invalid [1]. Group 1: Legal Victory - The Patent Trial and Appeal Board (PTAB) ruled in favor of Canadian Solar, invalidating all claims asserted by Maxeon against the company [1]. - This decision underscores the effectiveness of the international intellectual property protection framework and highlights Canadian Solar's strong technological foundation and legal capabilities [2]. Group 2: Company Overview - Canadian Solar is a leading global solar technology and renewable energy company, established in 2001 and headquartered in Kitchener, Ontario [4]. - The company has delivered nearly 170 GW of solar photovoltaic modules globally and has shipped over 16 GWh of battery energy storage solutions, with a contracted backlog of $3.1 billion as of October 31, 2025 [4]. - Canadian Solar has developed approximately 12 GWp of solar power projects and 6 GWh of battery energy storage projects since entering the project development business in 2010, with a diversified pipeline of 25 GWp of solar and 81 GWh of battery energy storage capacity in various development stages [4]. Group 3: Intellectual Property - Canadian Solar has filed over 5,000 patent applications and has been granted more than 4,000 patents, demonstrating its commitment to protecting intellectual property [3]. - The company emphasizes the importance of respecting intellectual property rights and opposes the misuse of patents that lack practical value [3].

Core Insights - The U.S. Court of Appeals for the Fifth Circuit upheld a $194 million award to DXC's subsidiary, CSC, for trade secret misappropriation by Tata Consultancy Services (TCS) [1][2] - The court affirmed that TCS acted willfully and maliciously in misappropriating CSC's trade secrets, with over $100 million awarded in punitive damages due to TCS's repeated deceitful actions [2] Company Commitment - DXC Technology emphasizes its commitment to responsible innovation, ethical conduct, and the protection of intellectual property as fundamental to its operations [3] - The ruling is seen as a validation of DXC's six-year pursuit of legal action to protect its intellectual property, which is crucial for maintaining customer trust [2][3] Leadership Perspective - CEO Raul Fernandez stated that trust, ethics, and responsible innovation are core principles guiding DXC's operations, highlighting the importance of safeguarding mission-critical systems for clients [3] - The company aims to ensure that innovation is deployed responsibly, thereby strengthening customer trust and driving long-term business outcomes [3] Company Overview - DXC Technology is a leading enterprise technology partner that provides software, services, and solutions to global enterprises and public sector organizations, focusing on AI and modernization [4] - The company specializes in Managed Infrastructure Services, Application Modernization, and Industry-Specific Software Solutions, operating complex technology estates [4]

New patent based on treatment of populations identified to be particularly responsive to ondansetron treatment after examination of Adial’s clinical data and informationGLEN ALLEN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the publication of the international patent application for AD04, f ...

As filed with the Securities and Exchange Commission on January 12, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Graphjet Technology (Exact name of registrant as specified in its charter) Cayman Islands 3620 N/A (State or other jurisdiction of incorporation or organization) (Primary standard industrial classification code number) (I.R.S. Employer Identification Number) Lot 3895, Lorong 6D, Kam ...

As filed with the Securities and Exchange Commission on January 12, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Graphjet Technology (Exact name of registrant as specified in its charter) Cayman Islands 3620 N/A (State or other jurisdiction of incorporation or organization) (Primary standard industrial classification code number) (I.R.S. Employer Identification Number) Lot 3895, Lorong 6D, Kam ...

Core Viewpoint - Scilex Holding Company has appointed Kasowitz LLP and its founding partner Marc Kasowitz as its litigation and intellectual property counsel to enhance its legal capabilities in protecting and advancing its proprietary pharmaceutical assets and development pipeline [1][2][3]. Company Overview - Scilex is focused on acquiring, developing, and commercializing non-opioid pain management products for treating acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases [4][7]. - The company targets high unmet needs and large market opportunities with non-opioid therapies, aiming to improve patient outcomes [4]. Product Portfolio - Scilex's commercial products include: - ZTlido (lidocaine topical system) 1.8%, approved by the FDA for neuropathic pain relief associated with postherpetic neuralgia [4]. - ELYXYB, the only FDA-approved ready-to-use oral solution for acute migraine treatment in adults [4]. - Gloperba, the first liquid oral version of colchicine for the prophylaxis of painful gout flares in adults [4]. - The company has three product candidates in development: - SP-102 (SEMDEXA™), a viscous gel formulation for epidural injections to treat lumbosacral radicular pain, which has completed a Phase 3 study and received Fast Track status from the FDA [5]. - SP-103, a next-generation lidocaine topical system for acute pain, which has completed a Phase 2 trial and also received Fast Track status [6]. - SP-104, a novel low-dose delayed-release naltrexone for fibromyalgia treatment [6]. Legal Counsel Appointment - Kasowitz LLP will provide advice on complex commercial litigation, patent litigation, intellectual property enforcement, and licensing matters [2]. - Marc Kasowitz is recognized for his expertise in high-stakes intellectual property and complex commercial litigation, enhancing Scilex's legal strategy [3].

Core Viewpoint - Datavault AI Inc. has strengthened its intellectual property and litigation capabilities by appointing Kasowitz LLP to enhance the protection and enforcement of its patented technologies in AI, data monetization, and digital twin sectors [1] Group 1: Company Developments - Datavault AI Inc. is a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies [1] - The company has appointed Kasowitz LLP and Marc Kasowitz to work alongside its existing counsel [1] - The focus of this appointment is to advise on intellectual property litigation, patent strategy, and technology-related disputes [1] Group 2: Technology Focus - The company is involved in proprietary technologies related to AI, data science, acoustic transmission, digital twin, and data monetization [1] - The appointment aims to bolster the protection and enforcement of these technologies [1]

Core Viewpoint - The Shanghai Xuhui District Procuratorate's third procuratorial department is focusing on integrating party building with business development in the artificial intelligence sector, aiming to support the sustainable growth of leading industries through innovative legal frameworks and community engagement [2][3]. Group 1: Integration of Legal and Technological Development - The party branch emphasizes the integration of political and business capabilities, utilizing red resources and various educational formats to enhance knowledge of party history, procuratorial history, and intellectual property law [2]. - A model for intellectual property protection has been recognized as one of the top ten innovative cases in Shanghai, showcasing the effectiveness of the integrated approach to legal education and case studies [2]. Group 2: Innovation and Risk Management - The establishment of a "Legal Vice Principal" role within the "Model Speed Space" aims to enhance legal oversight and risk management for AI enterprises, proposing 41 measures for operational risk prevention [3]. - A collaborative platform for intellectual property protection has been created, focusing on comprehensive protection strategies for foreign-related intellectual property [3]. Group 3: Talent Development and Professional Training - The party branch is integrating party groups with specialized case handling teams to enhance the effectiveness of legal services, encouraging members to take leadership roles in significant projects [4]. - There is a focus on cultivating high-caliber, multidisciplinary talent through dual training in political and business skills, particularly in handling complex cases related to AI and intellectual property [4]. Group 4: Community Engagement and Legal Services - Recent outreach efforts by the procuratorial staff included visits to local tech enterprises to provide legal services, demonstrating a commitment to supporting the innovation ecosystem [5].

Core Viewpoint - The company has recently obtained a national invention patent certificate for a flame retardant preparation method and application, which is expected to enhance its intellectual property protection and core competitiveness [1] Group 1: Patent Details - The patent is titled "A Preparation Method and Application of Flame Retardant MCA" with patent number ZL202310632257.8 [1] - The patent application date is May 31, 2023, and the authorization announcement date is December 23, 2025 [1] - The patent has a validity period of 20 years [1] Group 2: Impact on Business - The acquisition of the patent does not have a significant impact on the company's recent production and operations [1] - The patent is beneficial for improving the company's intellectual property protection system [1] - The patent is expected to enhance the company's core competitiveness in the industry [1]